SIRT1 and cancer: Considering that NNMT upregulation in the liver does not decrease NAD+ level, in contrast to adipose tissue, concomitant stabilization of SIRT1 by NNMT and the ability of liver to synthesize NAD+ de novo from Trp may allow for SIRT1 overactivation in this type of cancer.